The key genes for CSCs to maintain stemness, such as OCT4, SOX2, and NANOG, were also significantly decreased after the combination treatment (Fig. 2C and D), further implying that the stemness of CSCs was reduced and different from that of normal tumor cells. The gene discussed is SOX2; the disease is neoplasm.